Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Mycobacterium w
BIOLOGICAL
3 trials
Sponsors
Cadila Pharnmaceuticals
, Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions
Bladder Cancer
Sepsis
Phase 1
Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder
Completed
NCT00694798
Cadila Pharnmaceuticals
Bladder Cancer
Start: 2008-10-31
End: 2011-07-31
Updated: 2012-05-03
Phase 2
Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder
Completed
NCT00694915
Cadila Pharnmaceuticals
Bladder Cancer
Start: 2008-08-28
End: 2015-10-07
Updated: 2021-08-17
Mycobacterium w in Patients With Severe Sepsis
Completed
NCT02330432
Post Graduate Institute of Medical Education and Research, Chandigarh
Sepsis
Start: 2016-01-31
End: 2018-10-31
Updated: 2021-02-23
Related Papers
A Randomized Trial of Mycobacterium w in Severe Presumed Gram-Negative Sepsis.
2021-05-07
10 citations
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2019-04-17
10 citations